# Trending Content OS — Daily Run
**Date:** 2026-09-07 | **Niche:** Health & Wellness | **Geography:** US

---

## 1. Preflight Summary

```yaml
preflight_status:
  all_sections_present: true
  missing_sections: []
  site_niche_set: true
  target_audience_set: true
  site_url_set: false          # warn only — self-check unavailable, using competitor-list fallback
  serpapi_connected: true
  google_trends_available: true
  google_trends_tool: "serpapi_prefetch"
  search_velocity_source: "google_trends"
  active_tools: [serpapi_news, serpapi_trends, competitor_list_fallback]
  inactive_tools: [content_database, reddit_live_pull, exa_search]
  can_run_signal_listener: true
  notes: "site_url not configured — self-check skipped; competitor coverage (configs/competitor_list.yaml) used to inform SERP-gap/duplicate judgment instead. data/deferred_topics.yaml and data/run_history.yaml were not directly retrievable in this session; recency/duplicate judgment relied on the provided 'Recent Coverage (last 7 days)' list, which was treated as authoritative for dedup."
next_action: run_signal_listener
```

**Recurring theme flag:** "FDA recall surge / consumer distrust" has appeared as a distinct storyline in 5 of the last 6 days (09-01, 09-02, 09-03, 09-04, 09-06) — flagged as **recurring, check for staleness**. Today's recall-cluster items are held to a higher bar accordingly.

---

## 2. Google News Radar Coverage Summary

144 unique headlines across 12 queries clustered into six groups:

| Cluster | Examples | Disposition |
|---|---|---|
| **Institutional/administrative health ops** | [WBAL-TV — Luminis Health cyberattack](https://www.wbaltv.com/article/anne-arundel-medical-center-cyberattack/73596317), [Flathead Beacon — Logan Health no-confidence vote](https://flatheadbeacon.com/2026/09/04/logan-health-primary-care-providers-sign-vote-of-no-confidence-in-leadership/), [Source NM — 24% premium increase](https://sourcenm.com/2026/09/01/new-mexico-insurance-superintendent-approves-24-premium-increase-on-healthcare-exchange-plans/), NASA moon-base RFI, Ferguson executive order | **Rejected** — local/administrative/pure-business, no national patient-health angle |
| **Workplace & lifestyle wellness programs** | Fairfield wellness institute, Palo Alto self-care resources, spa launches, wellness weeks, 49ers mental-wellness event | **Rejected** — off-category (marketing/local events), no evidence-based health angle |
| **Medical research & clinical trials** | [Penn proton therapy](https://www.pennmedicine.org/news/penn-launches-first-advanced-proton-therapy-clinical-trial), [Ibogaine trial](https://news.asu.edu/20260831-health-and-medicine-barrow-asu-embark-one-first-clinical-trials-ibogaine-us), [Moderna Ebola vaccine](https://abcnews.com/Health/moderna-begins-phase-1-clinical-trial-ebola-vaccine/story?id=135365177), [Mount Sinai brain tumor radiation study](https://www.mountsinai.org/about/newsroom/2026/mount-sinai-researchers-report-largest-study-supporting-three-courses-of-radiation-for-children-with-deadly-brain-tumor), [Brown $37M aging alliance](https://www.brown.edu/news/2026-09-03/starr-healthspan-innovation-alliance), [AI drug "reverses biological age"](https://www.news-medical.net/news/20260907/AI-designed-drug-candidate-reverses-biological-age-in-clinical-study.aspx), [UCI laser pancreatic cancer trial](https://www.ucihealth.org/blog/2026/09/laser-light-pancreatic-cancer-trial) | **Mixed** — Penn/Ibogaine/Moderna/alcohol-cancer-study/social-media-study = existing (already covered); Mount Sinai + Brown = **Monitored** (thin, single-source, below trend threshold); AI biological-age drug = **Rejected** (unverifiable, severe overstatement risk); UCI trial = **Monitored** (single-source, no trial-registry ID) |
| **FDA/CDC recall & outbreak cluster** | [Blueberries E. coli → 17 illnesses (NYT)](https://www.nytimes.com/2026/09/05/health/frozen-blueberries-recall-e-coli.html), [Epinephrine recall (NewsNation)](https://www.newsnationnow.com/us-news/recalls/epinephrine-injection-recalled-health-risks-fda/), [IV fluids/fiberglass (Healthline)](https://www.healthline.com/health-news/fda-recalls-iv-saline-fluids-fiberglass-stainless-steel-contaminants), [Tofu recall (EatingWell)](https://www.eatingwell.com/tofu-recall-chemical-contamination-12097001), [Salmonella eggs outbreak (FDA)](https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-salmonella-eggs-july-2026), [Cyclospora lettuce (CDC)](https://www.cdc.gov/cyclosporiasis/outbreaks/07-26/index.html), [67% of shoppers avoid a food category (Fortune)](https://fortune.com/2026/09/02/food-recalls-fda-americans-avoid-food-categories/) | **Mostly existing/duplicate** — blueberries, epinephrine, tofu, cyclospora, Medtronic already covered. **Retained (new):** FDA Salmonella-eggs outbreak (distinct, primary FDA source). **Retained (update):** consumer-behavior/67%-avoidance stat = new data point on an already-covered theme. **Monitored:** IV fluids/fiberglass — insufficient corroboration (single source, no directly retrieved FDA notice) |
| **Drug approval / regulatory (non-US)** | [Biogen Leqembi subcutaneous — approved in China](https://investors.biogen.com/news-releases/news-release-details/leqembir-lecanemab-subcutaneous-formulation-initiation-treatment) | **Rejected** — no US FDA action, low near-term US-audience relevance |
| **Basic science / off-audience** | [Nature — genetic associations with personality](https://www.nature.com/articles/s41586-026-10992-9), Women in Clinical Trials feature, US News clinical-trial-access opinion | **Rejected** — edge-category basic science; feature/opinion pieces duplicate existing coverage or lack fresh data |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-09-07T00:00:00Z"
  run_completed_at: "2026-09-07T00:00:00Z"
  total_signals_reviewed: 144
  total_signals_retained: 2
  total_rejected: 20
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 8
    brand_safety: 0
    duplicate: 9
    weak_signal: 3
    unverified_claim: 1
    other: 0
  highest_priority_topic: "FDA Salmonella egg outbreak investigation"
  strongest_signal_source: "fda.gov / CDC.gov outbreak/recall notices"
  tools_unavailable: [content_database, live_reddit_pull, exa_search]
  notes: >
    Health-news volume today is dominated by the ongoing 2026 recall cycle, now recurring
    5 of the last 6 days — most individual recall items are duplicates of already-covered
    stories and were rejected on that basis. Google Trends shows a rising query
    ("cell metabolism keto diet study") with no corresponding article in this News Radar
    pre-fetch — flagged for a targeted search next run rather than scored on Trends data alone.
    Several single-source institutional research announcements (Mount Sinai, Brown University,
    UCI Health) are legitimate stories but lack corroborating pickup; routed to Monitor rather
    than forced into the board.
```

---

## 4. Skill 02b — Health Claim Verification Gate Routing Summary

| Topic | Risk Type | Primary Source Found | Gate Result | Notes |
|---|---|---|---|---|
| FDA Salmonella eggs outbreak | recall | Yes — [fda.gov](https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-salmonella-eggs-july-2026) | **Pass** | Direct FDA notice, claim matches source |
| IV fluids recall (fiberglass/stainless steel) | recall | No — only 1 secondary source (Healthline) | **Monitor** | Breaking-recall exception requires 3+ corroborating sources; only one captured in this pre-fetch. Hold for verification before scoring. |
| AI-designed drug "reverses biological age" | drug/treatment claim | No — single secondary source, no DOI/researcher named | **Reject** | Unverifiable health claim; "reverses biological age" is a severe-mismatch-risk phrase with no traceable primary study |
| Mount Sinai pediatric brain tumor radiation study | medical_study / dosage guidance | Yes — institutional (Mount Sinai newsroom, tier-1) | **Pass** (proceeded to 03–04, fell below trend threshold at 04) | Claim ("largest study supporting three courses of radiation") appears to match source; mild framing only |
| UCI Health first-in-human laser pancreatic trial | clinical_trial | No — single source, no ClinicalTrials.gov ID cited | **Monitor** | Needs trial-registry confirmation |
| Biogen Leqembi (China approval) | drug/treatment claim | Yes — manufacturer statement (primary-eligible) | **Pass** (proceeded, rejected downstream at Skill 02 for audience fit) | Gate passed on sourcing; rejected for low US-audience relevance, not for claim validity |

---

## 5. Final Editorial Priority Board

| Priority | Topic | Publish Timing | Trend | Opp. | Discover | Urgency | Confidence |
|---|---|---|---|---|---|---|---|
| **P2** | FDA Salmonella egg outbreak investigation | short_term | 64 | 67 | 4 | today | medium |
| **P3** | Recall fatigue: 67% of shoppers now avoid a food category after one FDA notice | scheduled | 51 | 64 | 3 | this_week | medium |
| **P5** | Mount Sinai — 3-course radiation protocol for pediatric brain tumor | monitor | 46 | 74 | — | evergreen | low |
| **P5** | Brown University $37M aging/healthspan research alliance | monitor | 34 | — | — | evergreen | low |
| **P5** | FDA IV fluids recall (fiberglass/stainless steel contamination) | monitor | n/a (02b hold) | n/a | — | today | low |
| **P5** | UCI Health first-in-human laser pancreatic cancer trial | monitor | n/a (02b hold) | n/a | — | this_week | low |

```yaml
summary:
  total_topics: 6
  high_priority_count: 1
  immediate_actions: "Brief and prep FDA Salmonella-egg outbreak story for short-term publish; verify IV fluids recall via direct FDA search before next run."
```

---

## 6. Editorial Briefs — Retained Candidates

### P2 — FDA Salmonella Egg Outbreak Investigation (Full Brief)

```yaml
priority_level: P2
publish_timing: short_term
topic: "FDA outbreak investigation: Salmonella linked to eggs (July 2026)"
primary_entity: "FDA Salmonella egg outbreak"
signal_type: recall
allowed_category: "FDA and CDC regulatory updates"
trend_strength_score: 64
opportunity_score: 67
discover_score: 4
urgency: today
confidence: medium
content_status: new
source_count: 1
recommended_angle: "What we actually know: which eggs, which states, and what to do if you bought them — cutting through this year's recall fatigue with the specific facts of this outbreak"
why_now: "FDA opened a formal outbreak investigation (09/03) distinct from the blueberry, sprout, and lettuce outbreaks already covered this week; readers need a clear, single-outbreak explainer rather than another generic recall roundup"
primary_headline: "FDA Investigates Salmonella Outbreak Linked to Eggs — What to Know"
next_steps: "Confirm case count/state list directly from FDA page before publish; monitor for CDC case-count updates; consider folding into a broader 'how to read a 2026 recall notice' evergreen sidebar given recall fatigue"
notes: "Part of a broader recall cluster (recurring theme, flagged for staleness) — differentiate from prior blueberry/sprout/lettuce coverage by keeping this narrowly focused on eggs only, not a recall-roundup piece"
brief:
  primary_headline: "FDA Investigates Salmonella Outbreak Linked to Eggs — What to Know"
  alternate_headlines:
    - "Salmonella Outbreak Tied to Eggs: FDA Investigation Explained"
    - "Eggs Recalled Over Salmonella Risk — Here's What's Confirmed So Far"
  search_intent: "informational + practical (what to do if I bought these eggs)"
  integrity_flags:
    - "⚠️ Integrity note: FDA investigations are often updated with new case counts and product lists after initial publication — confirm figures at time of writing, not from this brief."
  outline:
    intro: "Frame within 2026's record recall year without repeating prior recall coverage"
    sections:
      - "What FDA has confirmed (dates, states affected, product identifiers)"
      - "What Salmonella exposure risk looks like (symptoms, at-risk groups)"
      - "What to do if you have the product"
      - "How this differs from the other 2026 outbreaks (blueberries, sprouts, lettuce)"
    conclusion: "Practical takeaway + where to check for updates"
  key_data_points: ["FDA outbreak investigation opened 09/03/2026"]
  source_plan:
    - { publisher: "FDA", url: "https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-salmonella-eggs-july-2026", tier: 1, used_for: "Primary outbreak data" }
  evidence_requirements: "Light — FDA notice is primary source; supplement with CDC case-count page if available"
  expert_sources:
    - { type: "Public health official / CDC", reason: "Salmonella risk context and at-risk population guidance" }
  seo:
    primary_keyword: "salmonella eggs recall 2026"
    supporting_keywords: ["FDA egg outbreak", "salmonella symptoms eggs", "egg recall states"]
    format: "News explainer, 600-800 words"
  discover_notes: "Specific named entity (Salmonella/eggs) + direct FDA source + clear Q&A fit ('which eggs are recalled') = solid AI-citation potential"
  estimated_word_count: "600-800"
execution_notes: "Hold for FDA case-count confirmation immediately before publish given investigation is still open"
confidence: medium
```

### P3 — Recall Fatigue / Consumer Behavior Update (Concise Brief)

```yaml
priority_level: P3
publish_timing: scheduled
topic: "67% of shoppers now avoid a food category after a single FDA recall notice"
primary_entity: "FDA recall fatigue — consumer behavior"
signal_type: audience_pain_point
allowed_category: "FDA and CDC regulatory updates"
trend_strength_score: 51
opportunity_score: 64
discover_score: 3
urgency: this_week
confidence: medium
content_status: update
source_count: 3
recommended_angle: "New survey data (67% avoidance) updates the consumer-trust story already covered 09/03 — focus on what's actually driving overcaution vs. genuine risk"
why_now: "New survey stat (67%) published since prior consumer-behavior coverage; quantifies a trend previously covered only qualitatively"
primary_headline: "Recall Fatigue Is Real: 67% of Shoppers Now Avoid Entire Food Categories"
next_steps: "Confirm this is genuinely new data vs. restated figure from 09/03 coverage before publishing as 'update'"
notes: "⚠️ Recurring theme — this is the 3rd distinct piece of coverage on recall-fatigue/consumer-trust angle in under a week; keep this one data-led and short rather than re-explaining the full recall backdrop"
brief:
  headline: "Recall Fatigue Is Real: 67% of Shoppers Now Avoid Entire Food Categories"
  angle: "Ground the behavioral-economics angle in the actual survey data rather than repeating the recall list — answer 'is this overcaution justified?' with FDA context."
  key_data_points: ["67% of surveyed shoppers avoid a whole food category after one recall notice (Fortune)"]
  integrity_flags: ["⚠️ Integrity note: single survey/publisher-sourced statistic — confirm methodology and sample size before treating as representative."]
  expert_type_needed: "Risk-communication researcher or public health official"
  seo:
    primary_keyword: "food recall consumer trust 2026"
    format: "News analysis, 500-700 words"
    serp_difficulty: Medium
  sources:
    - { publisher: "Fortune", url: "https://fortune.com/2026/09/02/food-recalls-fda-americans-avoid-food-categories/" }
  estimated_word_count: "500-700"
```

---

## 7. Rejected Topics Log

| Topic | Reason |
|---|---|
| Frozen blueberries E. coli (17 illnesses) | Existing — already covered 09-06, no new development beyond confirmed count |
| Epinephrine injection recall | Existing — covered 09-04 |
| Cyclospora/iceberg lettuce outbreak | Existing — covered 09-06 |
| Tofu chemical contamination recall | Existing — covered as part of 09-02 recall roundup |
| Medtronic Bravo CF recall | Existing — covered 09-01 |
| Alcohol-related cancer deaths doubled since 1990 | Existing — covered 09-06 |
| Stanford social media health-warning study | Existing — covered 09-06 (duplicate appearance via Medical Xpress) |
| Penn proton therapy clinical trial | Existing — covered 09-04 |
| Barrow/ASU ibogaine trial | Existing — covered 09-02 |
| Moderna Ebola vaccine Phase 1 | Existing — covered 09-02, no new milestone stated |
| "America has a clinical trial problem" (US News opinion) | Duplicate of existing "cancer clinical trial access" coverage (09-02) |
| Women in Clinical Trials: History and Impact | Weak signal — evergreen feature, no new data, low urgency today |
| Nature: genetic associations with personality | Off-category — basic science, no direct health-action angle |
| AI-designed drug "reverses biological age" | Unverified claim — failed Skill 02b, single source, no traceable primary study, severe-overstatement risk |
| Biogen Leqembi subcutaneous approval (China) | Off-audience — no US FDA action, low near-term relevance to US readers |
| Institutional/admin cluster (hospital cyberattack, staffing votes, insurance premiums, rankings, NASA moon base, governor EO) | Off-category — local/administrative/pure-business, no national health angle |
| Workplace & lifestyle wellness cluster (spa launches, wellness weeks, employee programs) | Off-category — marketing/local events, no evidence-based angle |
| "Cell metabolism keto diet study" (Trends-only rising query) | Weak signal — no corroborating article in News Radar pre-fetch; flagged for targeted search next run rather than scored |
| JD Vance weight loss | Excluded — political figure / celebrity-adjacent, no health-evidence angle |
| "Planet Fitness Labor Day hours" rising query | Noise — logistics query, not editorial content |

---

## 8. Integrity Flags (Consolidated)

- ⚠️ FDA egg outbreak: case counts/product list are subject to change — confirm at time of publish, not from this brief.
- ⚠️ Recall-fatigue survey stat (67%): single-publisher survey data — verify sample size/methodology before treating as representative; distinguish justified caution from overcaution.
- ⚠️ Mount Sinai radiation-protocol study (Monitor): "largest study supporting three courses of radiation" is a treatment-protocol claim — if promoted to full brief later, must note study design (observational vs. RCT) and avoid implying a new standard of care beyond what the institution states.
- ⚠️ AI "reverses biological age" drug candidate: rejected specifically because the claim could not be traced to a primary source — do not resurface without a DOI/PubMed/named-researcher trail.

---

## 9. Run Notes

- Recall-cycle stories continue to dominate raw signal volume but increasingly duplicate prior coverage — today's board deliberately holds the line at 2 retained recall-adjacent items instead of re-covering the full cluster.
- Two legitimate research stories (Mount Sinai, Brown University) were held at Monitor purely on single-source/low-search-velocity grounds, not on credibility — worth rechecking in 2–3 days for secondary pickup before reconsidering.
- IV fluids recall and UCI pancreatic trial need direct verification (FDA.gov / ClinicalTrials.gov) before they can be scored — flagged for tomorrow's run rather than guessed at.
- `data/deferred_topics.yaml` / `data/run_history.yaml` were not directly accessible this session; run archival should be performed by the pipeline harness (`run_pipeline.py`) as usual — this report should be treated as the source content for that write-back.
- No dashboard HTML was generated in this conversation; recommend passing this report through the standard `run_pipeline.py` archival step to produce `outputs/daily_newsroom_dashboard/2026-09-07.html` and update run history.